速効型インスリンの世界市場:企業別、地域別、種類別、用途別、市場予測(~2024)

【英語タイトル】Global Rapid Acting Insulins Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料(GIR9090583)・商品コード:GIR9090583
・発行会社(調査会社):GlobalInfoResearch
・発行日:2019年9月13日
・ページ数:104
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥361,920見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥542,880見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥723,840見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、速効型インスリンの世界市場について調べ、まとめました。種類別セグメントは、リスプロ、アスパート(ノボラピッド)、グルリジン(アピドラ)等、用途別セグメントは、1型糖尿病、2型糖尿病等に区分しました。速効型インスリンの世界市場概観、企業動向、企業別速効型インスリンシェア、市場規模推移、市場規模予測(2019年-2024年)、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・速効型インスリンの市場概観
・速効型インスリンの企業概要(事業概要、製品種類、販売量、価格、売上、市場シェア等)
・速効型インスリンの企業別販売動向、市場シェア、市場集中度、競争動向
・速効型インスリンの世界市場規模
・速効型インスリンの北米市場分析(アメリカ、カナダ、メキシコ等)
・速効型インスリンのアメリカ市場規模推移
・速効型インスリンのカナダ市場規模推移
・速効型インスリンのメキシコ市場規模推移
・速効型インスリンのヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・速効型インスリンのドイツ市場規模推移
・速効型インスリンのイギリス市場規模推移
・速効型インスリンのロシア市場規模推移
・速効型インスリンのアジア太平洋市場分析(日本、中国、韓国、インド、東南アジア等)
・速効型インスリンの日本市場規模推移
・速効型インスリンの中国市場規模推移
・速効型インスリンの韓国市場規模推移
・速効型インスリンのインド市場規模推移
・速効型インスリンの東南アジア市場規模推移
・速効型インスリンの南米市場分析(ブラジル、アルゼンチン等)
・速効型インスリンの中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・速効型インスリンの種類別分析/販売量、売上、市場シェア(リスプロ、アスパート(ノボラピッド)、グルリジン(アピドラ))
・速効型インスリンの用途別分析/市場規模(1型糖尿病、2型糖尿病)
・速効型インスリンの市場予測2019年-2024年(地域別予測、種類別予測、用途別予測)
・速効型インスリンの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Rapid Acting Insulins are usually taken before or with a meal. They act very quickly to minimise the rise in blood sugar which follows eating. Rapid acting insulins can be used for both type 1 and type 2 diabetes, injected or delivered via an insulin pump.

Scope of the Report:
The global Rapid Acting Insulins market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rapid Acting Insulins.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Rapid Acting Insulins market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rapid Acting Insulins market by product type and applications/end industries.

Market Segment by Companies, this report covers
Eli Lilly
Novo Nordisk
Sanofi

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Lispro
Aspart (NovoLog)
Glulisine (Apidra)

Market Segment by Applications, can be divided into
Type 1 Diabetes
Type 2 Diabetes

【レポートの目次】

Table of Contents

1 Rapid Acting Insulins Market Overview
1.1 Product Overview and Scope of Rapid Acting Insulins
1.2 Classification of Rapid Acting Insulins by Types
1.2.1 Global Rapid Acting Insulins Revenue Comparison by Types (2019-2024)
1.2.2 Global Rapid Acting Insulins Revenue Market Share by Types in 2018
1.2.3 Lispro
1.2.4 Aspart (NovoLog)
1.2.5 Glulisine (Apidra)
1.3 Global Rapid Acting Insulins Market by Application
1.3.1 Global Rapid Acting Insulins Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Global Rapid Acting Insulins Market by Regions
1.4.1 Global Rapid Acting Insulins Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Rapid Acting Insulins Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Rapid Acting Insulins Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rapid Acting Insulins Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Rapid Acting Insulins Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rapid Acting Insulins Status and Prospect (2014-2024)
1.5 Global Market Size of Rapid Acting Insulins (2014-2024)
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 Rapid Acting Insulins Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly Rapid Acting Insulins Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novo Nordisk
2.2.1 Business Overview
2.2.2 Rapid Acting Insulins Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novo Nordisk Rapid Acting Insulins Revenue, Gross Margin and Market Share (2017-2018)
2.3 Sanofi
2.3.1 Business Overview
2.3.2 Rapid Acting Insulins Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Rapid Acting Insulins Revenue, Gross Margin and Market Share (2017-2018)
3 Global Rapid Acting Insulins Market Competition, by Players
3.1 Global Rapid Acting Insulins Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Rapid Acting Insulins Players Market Share
3.2.2 Top 10 Rapid Acting Insulins Players Market Share
3.3 Market Competition Trend
4 Global Rapid Acting Insulins Market Size by Regions
4.1 Global Rapid Acting Insulins Revenue and Market Share by Regions
4.2 North America Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
4.3 Europe Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
4.5 South America Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
5 North America Rapid Acting Insulins Revenue by Countries
5.1 North America Rapid Acting Insulins Revenue by Countries (2014-2019)
5.2 USA Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
5.3 Canada Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
5.4 Mexico Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
6 Europe Rapid Acting Insulins Revenue by Countries
6.1 Europe Rapid Acting Insulins Revenue by Countries (2014-2019)
6.2 Germany Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
6.3 UK Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
6.4 France Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
6.5 Russia Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
6.6 Italy Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Rapid Acting Insulins Revenue by Countries
7.1 Asia-Pacific Rapid Acting Insulins Revenue by Countries (2014-2019)
7.2 China Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
7.3 Japan Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
7.4 Korea Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
7.5 India Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
8 South America Rapid Acting Insulins Revenue by Countries
8.1 South America Rapid Acting Insulins Revenue by Countries (2014-2019)
8.2 Brazil Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
8.3 Argentina Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
8.4 Colombia Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Rapid Acting Insulins by Countries
9.1 Middle East and Africa Rapid Acting Insulins Revenue by Countries (2014-2019)
9.2 Saudi Arabia Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
9.3 UAE Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
9.4 Egypt Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
9.5 Nigeria Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
9.6 South Africa Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
10 Global Rapid Acting Insulins Market Segment by Type
10.1 Global Rapid Acting Insulins Revenue and Market Share by Type (2014-2019)
10.2 Global Rapid Acting Insulins Market Forecast by Type (2019-2024)
10.3 Lispro Revenue Growth Rate (2014-2024)
10.4 Aspart (NovoLog) Revenue Growth Rate (2014-2024)
10.5 Glulisine (Apidra) Revenue Growth Rate (2014-2024)
11 Global Rapid Acting Insulins Market Segment by Application
11.1 Global Rapid Acting Insulins Revenue Market Share by Application (2014-2019)
11.2 Rapid Acting Insulins Market Forecast by Application (2019-2024)
11.3 Type 1 Diabetes Revenue Growth (2014-2019)
11.4 Type 2 Diabetes Revenue Growth (2014-2019)
12 Global Rapid Acting Insulins Market Size Forecast (2019-2024)
12.1 Global Rapid Acting Insulins Market Size Forecast (2019-2024)
12.2 Global Rapid Acting Insulins Market Forecast by Regions (2019-2024)
12.3 North America Rapid Acting Insulins Revenue Market Forecast (2019-2024)
12.4 Europe Rapid Acting Insulins Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Rapid Acting Insulins Revenue Market Forecast (2019-2024)
12.6 South America Rapid Acting Insulins Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Rapid Acting Insulins Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Rapid Acting Insulins Picture
Table Product Specifications of Rapid Acting Insulins
Table Global Rapid Acting Insulins and Revenue (Million USD) Market Split by Product Type
Figure Global Rapid Acting Insulins Revenue Market Share by Types in 2018
Figure Lispro Picture
Figure Aspart (NovoLog) Picture
Figure Glulisine (Apidra) Picture
Table Global Rapid Acting Insulins Revenue (Million USD) by Application (2014-2024)
Figure Rapid Acting Insulins Revenue Market Share by Applications in 2018
Figure Type 1 Diabetes Picture
Figure Type 2 Diabetes Picture
Table Global Market Rapid Acting Insulins Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Rapid Acting Insulins Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Rapid Acting Insulins Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Rapid Acting Insulins Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Rapid Acting Insulins Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Rapid Acting Insulins Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Rapid Acting Insulins Revenue (Million USD) and Growth Rate (2014-2024)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Rapid Acting Insulins Type and Applications
Table Eli Lilly Rapid Acting Insulins Revenue, Gross Margin and Market Share (2017-2018)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Rapid Acting Insulins Type and Applications
Table Novo Nordisk Rapid Acting Insulins Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Rapid Acting Insulins Type and Applications
Table Sanofi Rapid Acting Insulins Revenue, Gross Margin and Market Share (2017-2018)
Table Global Rapid Acting Insulins Revenue (Million USD) by Players (2014-2019)
Table Global Rapid Acting Insulins Revenue Share by Players (2014-2019)
Figure Global Rapid Acting Insulins Revenue Share by Players in 2017
Figure Global Rapid Acting Insulins Revenue Share by Players in 2018
Figure Global Top 5 Players Rapid Acting Insulins Revenue Market Share in 2018
Figure Global Top 10 Players Rapid Acting Insulins Revenue Market Share in 2018
Figure Global Rapid Acting Insulins Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Rapid Acting Insulins Revenue (Million USD) by Regions (2014-2019)
Table Global Rapid Acting Insulins Revenue Market Share by Regions (2014-2019)
Figure Global Rapid Acting Insulins Revenue Market Share by Regions (2014-2019)
Figure Global Rapid Acting Insulins Revenue Market Share by Regions in 2018
Figure North America Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Europe Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure South America Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Table North America Rapid Acting Insulins Revenue by Countries (2014-2019)
Table North America Rapid Acting Insulins Revenue Market Share by Countries (2014-2019)
Figure North America Rapid Acting Insulins Revenue Market Share by Countries (2014-2019)
Figure North America Rapid Acting Insulins Revenue Market Share by Countries in 2018
Figure USA Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Canada Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Mexico Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Table Europe Rapid Acting Insulins Revenue (Million USD) by Countries (2014-2019)
Figure Europe Rapid Acting Insulins Revenue Market Share by Countries (2014-2019)
Figure Europe Rapid Acting Insulins Revenue Market Share by Countries in 2018
Figure Germany Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure UK Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure France Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Russia Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Italy Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Rapid Acting Insulins Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Rapid Acting Insulins Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Rapid Acting Insulins Revenue Market Share by Countries in 2018
Figure China Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Japan Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Korea Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure India Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Table South America Rapid Acting Insulins Revenue by Countries (2014-2019)
Table South America Rapid Acting Insulins Revenue Market Share by Countries (2014-2019)
Figure South America Rapid Acting Insulins Revenue Market Share by Countries (2014-2019)
Figure South America Rapid Acting Insulins Revenue Market Share by Countries in 2018
Figure Brazil Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Argentina Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Colombia Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Rapid Acting Insulins Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Rapid Acting Insulins Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Rapid Acting Insulins Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Rapid Acting Insulins Revenue Market Share by Countries in 2018
Figure Saudi Arabia Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure UAE Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Egypt Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure Nigeria Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Figure South Africa Rapid Acting Insulins Revenue and Growth Rate (2014-2019)
Table Global Rapid Acting Insulins Revenue (Million USD) by Type (2014-2019)
Table Global Rapid Acting Insulins Revenue Share by Type (2014-2019)
Figure Global Rapid Acting Insulins Revenue Share by Type (2014-2019)
Figure Global Rapid Acting Insulins Revenue Share by Type in 2019
Table Global Rapid Acting Insulins Revenue Forecast by Type (2019-2024)
Figure Global Rapid Acting Insulins Market Share Forecast by Type (2019-2024)
Figure Global Lispro Revenue Growth Rate (2014-2019)
Figure Global Aspart (NovoLog) Revenue Growth Rate (2014-2019)
Figure Global Glulisine (Apidra) Revenue Growth Rate (2014-2019)
Table Global Rapid Acting Insulins Revenue by Application (2014-2019)
Table Global Rapid Acting Insulins Revenue Share by Application (2014-2019)
Figure Global Rapid Acting Insulins Revenue Share by Application (2014-2019)
Figure Global Rapid Acting Insulins Revenue Share by Application in 2019
Table Global Rapid Acting Insulins Revenue Forecast by Application (2019-2024)
Figure Global Rapid Acting Insulins Market Share Forecast by Application (2019-2024)
Figure Global Type 1 Diabetes Revenue Growth Rate (2014-2019)
Figure Global Type 2 Diabetes Revenue Growth Rate (2014-2019)
Figure Global Rapid Acting Insulins Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Rapid Acting Insulins Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Rapid Acting Insulins Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Rapid Acting Insulins Revenue Market Forecast (2019-2024)
Figure Europe Rapid Acting Insulins Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Rapid Acting Insulins Revenue Market Forecast (2019-2024)
Figure South America Rapid Acting Insulins Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Rapid Acting Insulins Revenue Market Forecast (2019-2024)


【掲載企業】

Eli Lilly、Novo Nordisk、Sanofi、

★調査レポート[速効型インスリンの世界市場:企業別、地域別、種類別、用途別、市場予測(~2024)] (コード:GIR9090583)販売に関する免責事項を必ずご確認ください。
★調査レポート[速効型インスリンの世界市場:企業別、地域別、種類別、用途別、市場予測(~2024)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆